2024 Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview: Key Insights on Size, Share, and Trends
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What is the Anticipated Growth Speed of the Ribose-Nucleic Acid (RNA)-Based TherapeuticsMarket Between 2024 and 2033?
The ribose-nucleic acid (RNA)-based therapeutics market size has grown strongly in recent years, projected to increase from $14.54 billion in 2023 to $15.79 billion in 2024, with a CAGR of 8.6%. The growth in the historical period can be attributed to increased investment and funding, discoveries in RNA interference (RNAi), successful clinical applications of antisense oligonucleotides (ASOs), regulatory support, and partnerships.
The RNA-based therapeutics market is anticipated to grow to $22.30 billion by 2028, at a CAGR of 9.0%. Growth drivers include expanded indications, regulatory support, and AI integration in drug development. Emerging trends involve advanced delivery systems, multi-target therapies, and regulatory advancements.
Which Factors Are Enhancing the Growth of the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
The increasing occurrence of cancer is expected to accelerate the growth of the ribose-nucleic acid (RNA)-based therapeutics market in the future. Cancer is characterized by the uncontrolled growth and spread of abnormal cells, which can lead to death if not treated. Factors contributing to the prevalence of cancer include an aging population, lifestyle changes, heightened exposure to risk factors, and improved detection techniques. RNA-based therapeutics represent a promising approach to cancer treatment by targeting the genetic and molecular mechanisms associated with the disease.
Claim Your Free Sample of the Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=18454&type=smp
Which Segments Are Crucial in the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
The ribose-nucleic acid (RNA)-based therapeutics market covered in this report is segmented –
1) By Type: RNA Interference (RNAi), RNA Antisense
2) By Technology: Enabling Technology, Enabled Technology
3) By Therapeutic Area: Oncology, Genetic Disorder, Opthalmology, Hematological Disorders, Acute Hepatic Porphyria (AHP), Other Therapeutic Areas
4) By End User: Research Institutes, Hospitals And Clinics
What Emerging Trends Are Shaping the Future of the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
Major companies operating in the ribose nucleic acid (RNA)-based therapeutics market are committed to creating innovative medical solutions, such as messenger RNA (mRNA)-based booster vaccines, to improve vaccination effectiveness, tackle emerging viral variants, and boost the durability of vaccine-induced immunity. An mRNA-based booster vaccine utilizes messenger RNA to stimulate cells to produce a protein that enhances the immune response against a specific pathogen. For example, in June 2023, Gennova Biopharmaceuticals Ltd., an Indian pharmaceutical company, introduced GEMCOVAC-OM, India’s first mRNA booster vaccine specifically aimed at the Omicron variant of COVID-19. This booster is crucial due to the limited efficacy of original vaccines against Omicron. By employing mRNA technology, GEMCOVAC-OM enhances immunity and provides better protection against the evolving virus.
Order Now for Fast Delivery of Your Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Report!
What Regions Are At the Forefront of Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Expansion?
North America was the largest region in the ribose-nucleic acid (RNA)-based therapeutics market in 2023. The regions covered in the ribose-nucleic acid (RNA)-based therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Ribose-Nucleic Acid (RNA)-Based Therapeutics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the ribose-nucleic acid (rna)-based therapeutics market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Include
1. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Executive Summary
2. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Segments
3. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Size And Template Market Growth Rate
4. Key Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Trends
5. Major Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Drivers
……
25. Key Mergers And Acquisitions In The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market
26. Top Ribose-Nucleic Acid (RNA)-Based Therapeutics Companies
27. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Opportunities And Strategies
28. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Nucleic Acid Based Gene Therapy Market Size, Share, Analysis and Forecast 2033
Nucleic Acid Isolation & Purification Global Market Report 2024
Automated Nucleic Acid Extraction Devices Global Market Report 2024
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
